September 19, 2014
September 18, 2014
September 17, 2014
Office of the Inspector General "OIG" Publishes New Physician Compliance Guidance
The Office of the Inspector General for the U.S. Department of Health and Human Services has published a new guidance document for physicians on compliance with healthcare fraud and abuse laws. The document, A Roadmap for Physicians: Avoiding Medicare Fraud and Abuse, summarizes the five main federal fraud and abuse laws: the False Claims Act; the Anti-Kickback statute; the Physician Self-Referral Law (“Stark”), the Medicare exclusion statute; and the Civil Monetary Penalties (“CMP”) law. These materials then offer guidance on how physicians can comply with these laws in their relations with vendors, payers, and other providers. Examples include practical advice on such issues as coding, documentation, investments in health care business ventures, physician recruitment, and medical director arrangements. These materials may be found on the OIG website by following this link.
Daniel Levinson, HHS Inspector General, and Lew Morris, Chief Counsel to the Inspector General, both alluded to these new resources during testimony on March 2 before the U.S. Senate Committee on Finance, where they spoke on OIG’s collaboration with members of the private sector in their efforts to combat fraud. Messrs. Levinson and Morris also described two other ongoing initiatives aimed at strengthening the integrity of the Medicare and Medicaid programs, involving the targeting of “hot spots” with Medicare Fraud Strike Teams and increased utilization of exclusion and other tools when dealing with “untrustworthy” providers. This testimony is also accessible on the OIG website.
<span class="advertise"> Advertisement </span>
- U.S. Government Accountability Office (GAO) Report Outlines Healthcare.gov’s Ongoing Privacy Issues
- HIPAA Omnibus Rule: Deadline Approaching to Update Grandfathered Business Associate Agreements
- Reminder: Update Your “Grandfathered” HIPAA Business Associate Agreements Now!
- HIPAA Privacy Rule Also Affected By Supreme Court’s DOMA Decision in U.S. v. Windsor
- September 15, 2014 Regulatory Developments New Jersey Health Care
- 340B Federal Drug Pricing Program September Update: Self-Disclosures